Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:31 PM
Ignite Modification Date:
2025-12-24 @ 5:31 PM
NCT ID:
NCT07232368
Eligibility Criteria:
Inclusion Criteria:
* Being between 18 and 65 years of age
* Being diagnosed with PAH (pulmonary arterial hypertension)- (Group I pulmonary hypertension (idiopathic, hereditary, drug or toxin-induced, or associated with connective tissue disease, congenital heart disease, or HIV-associated)) diagnosed by right heart catheterization
* Being on stable PAH treatment for the past three months and in a stable clinical condition (no changes in PAH medical treatment, no new medications added)
* Being in class II or III according to the World Health Organization functional classification
* Being able to speak Turkish
* Having a high level of technical digital literacy (obtaining the highest score (30 points) on the "technical subscale" of the Digital Literacy Scale\*)
* Agreeing to participate in the study
Exclusion Criteria:
* Communication difficulties
* Symptomatic hypotension
* Pregnancy status for female participants (positive urine pregnancy test\*)
* Presence of another underlying condition that may cause dyspnea, fatigue, and sleep difficulties (chronic fatigue syndrome, obstructive sleep apnea, restless legs syndrome, narcolepsy, major depression, etc.)
* Hospitalization or acute phase
* Active participation in a cardiac rehabilitation program
* Presence of pulmonary hypertension due to left heart disease and pulmonary hypertension due to lung diseases and/or hypoxia
* Receiving a lung transplant
* Having had cardiac surgery within the last six months
* Presence of obesity
* Presence of mental retardation
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
65 Years
Study:
NCT07232368
Study Brief:
Protocol Section:
NCT07232368